MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent, covering 2016-11-25 to 2016-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) [Phase 2]